Stay updated on MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.2 to v3.5.3, indicating a backend update to the page content managed by ClinicalTrials.gov.
    Difference
    0.0%
    Check dated 2026-04-30T17:03:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; a minor technical update with no changes to study data.
    Difference
    0.0%
    Check dated 2026-04-16T09:32:51.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision metadata updated: added revision note for v3.5.0. The previous v3.4.3 revision entry was removed.
    Difference
    0.0%
    Check dated 2026-03-25T19:51:57.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:48:19.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The screenshots show the same study details with no additions or deletions detected.
    Difference
    0.0%
    Check dated 2026-03-04T09:31:50.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The trial record now indicates Terminated status and a new Phase 1 SOS1 inhibitor study of MRTX0902 with 64 participants, including Phase 1 dose escalation and expansion cohorts, replacing prior Phase 1/2 entries.
    Difference
    2%
    Check dated 2026-02-25T06:51:15.000Z thumbnail image

Stay in the know with updates to MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.